Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,194 | 52,744 | 58,338 | 82,085 | 112,146 |
| Marketable Securities | 193,038 | 175,794 | 189,325 | 211,284 | 227,778 |
| Receivables | 2,261 | 3,203 | 2,417 | 3,096 | 3,618 |
| Other current assets | 1,481 | 1,639 | 2,247 | 1,899 | 2,093 |
| TOTAL | $268,538 | $239,490 | $260,248 | $306,922 | $352,928 |
| Non-Current Assets | |||||
| PPE Net | 15,429 | 12,646 | 10,678 | 8,959 | 8,006 |
| Investments And Advances | 41,055 | 70,135 | 77,071 | 56,980 | 33,880 |
| Other Non-Current Assets | 24,625 | 25,191 | 25,768 | 25,962 | 26,553 |
| TOTAL | $81,109 | $107,972 | $113,517 | $91,901 | $68,439 |
| Total Assets | $349,647 | $347,462 | $373,765 | $398,823 | $421,367 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,433 | 2,651 | 1,146 | 1,228 | 426 |
| Accrued Expenses | 15,901 | 12,544 | 16,079 | 14,638 | 14,910 |
| TOTAL | $34,375 | $27,100 | $28,128 | $28,814 | $28,855 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,962 | 10,883 | 9,937 | 12,036 | 12,642 |
| Other Non-Current Liabilities | 27,272 | 27,797 | 28,431 | 29,997 | 28,522 |
| TOTAL | $45,814 | $42,090 | $44,766 | $45,895 | $44,623 |
| Total Liabilities | $80,189 | $69,190 | $72,894 | $74,709 | $73,478 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,285 | 61,364 | 61,300 | 61,002 | 60,840 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -254,778 | -225,259 | -197,215 | -170,226 | -143,579 |
| Other shareholders' equity | -1,136 | -730 | -1,518 | -2,035 | -1,581 |
| TOTAL | $269,458 | $278,272 | $300,871 | $324,114 | $347,889 |
| Total Liabilities And Equity | $349,647 | $347,462 | $373,765 | $398,823 | $421,367 |